What's New
- Exceptional Returns II
This report estimates the economic value of health R&D in Australia, updating the Access Economics (2003) Exceptional Returns Report for the ASMR in light of recent increases in health R&D expenditures. - Don Russell's Speech - Chris Higgins Prize : 30 April 2008
- The Burden of VTE in Australia
Access Economics was commissioned by the VTE Taskforce to estimate the incidence, financial impact and burden of disease from venous thromboembolism ) (VTE) in Australia for the year 2008, to raise awareness of the impact of VTE.
Access Economics has concluded that based on epidemiological evidence, VTE was estimated to be responsible for 5,285 deaths in Australia in 2008. While this is higher than previously estimated, it is conservative compared to recent per capita estimates 50% higher in the UK and 4 times higher in the US.
Compared to other conditions costed by Access Economics, VTE is second only to muscular dystrophy on a financial cost per case basis. If the heavy dollar value of the burden of disease cost from premature mortality is included, VTE ranks most costly overall.
|
|
Publication Release Dates
|
|
